The Cytopathologist's Expanding Role in the 2018 Updated Molecular Testing Guidelines for Lung Cancer

Cancer cytopathology - United States
doi 10.1002/cncy.22060
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Molecular Testing for Early Lung Cancer

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2018English

Keeping Up With Testing Guidelines in Lung Cancer

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2018English

The Role of Cytology in Molecular Testing and Personalized Medicine in Lung Cancer: A Clinical Perspective

Cancer cytopathology
Cancer ResearchOncology
2018English

Adjusting for Youth: Updated Cancer Risk Guidelines

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2003English

Updated Guidelines for Predictive Biomarker Testing in Advanced Non-Small-Cell Lung Cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2019English

P1.02-03 the Role of Lung Cancer Advocacy Organizations in Biomarker Testing

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Guidelines for the Treatment of Lung Cancer Using Radiotherapy

Revista da Associacao Medica Brasileira
Medicine
2017English

Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2016English

Physician Attitudes and Prevalence of Molecular Testing in Lung Cancer

Journal of Community and Supportive Oncology
OncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy